Amedisys Inc (AMED) - Total Liabilities
Based on the latest financial reports, Amedisys Inc (AMED) has total liabilities worth $940.48 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore AMED long-term investment intensity to see how much of total assets are deployed in long-term investments.
Amedisys Inc - Total Liabilities Trend (1993–2024)
This chart illustrates how Amedisys Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see AMED asset base.
Amedisys Inc Competitors by Total Liabilities
The table below lists competitors of Amedisys Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SSAB AB (publ)
ST:SSAB-A
|
Sweden | Skr38.39 Billion |
|
Catcher Technology Co Ltd
TW:2474
|
Taiwan | NT$87.37 Billion |
|
Kunshan Kinglai Hygienic Materials Co Ltd
SHE:300260
|
China | CN¥3.37 Billion |
|
Luxi Chemical Group Co Ltd
SHE:000830
|
China | CN¥16.76 Billion |
|
Lotus Health Group Co
SHG:600186
|
China | CN¥1.62 Billion |
|
China Zhenhua Group Science & Technology Co Ltd
SHE:000733
|
China | CN¥3.22 Billion |
|
Jiangxi Jovo Energy Co. Ltd
SHG:605090
|
China | CN¥5.66 Billion |
|
Krishna Institute of Medical Sciences Limited
NSE:KIMS
|
India | Rs52.00 Billion |
Liability Composition Analysis (1993–2024)
This chart breaks down Amedisys Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See AMED net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Amedisys Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Amedisys Inc (1993–2024)
The table below shows the annual total liabilities of Amedisys Inc from 1993 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $958.75 Million | +1.95% |
| 2023-12-31 | $940.39 Million | +8.13% |
| 2022-12-31 | $869.67 Million | -1.25% |
| 2021-12-31 | $880.64 Million | +16.42% |
| 2020-12-31 | $756.46 Million | +21.77% |
| 2019-12-31 | $621.23 Million | +164.93% |
| 2018-12-31 | $234.49 Million | -21.06% |
| 2017-12-31 | $297.06 Million | +8.86% |
| 2016-12-31 | $272.89 Million | -0.64% |
| 2015-12-31 | $274.65 Million | +0.98% |
| 2014-12-31 | $271.98 Million | -23.15% |
| 2013-12-31 | $353.93 Million | +28.07% |
| 2012-12-31 | $276.36 Million | -18.27% |
| 2011-12-31 | $338.14 Million | -19.51% |
| 2010-12-31 | $420.11 Million | -3.65% |
| 2009-12-31 | $436.02 Million | -14.18% |
| 2008-12-31 | $508.08 Million | +264.76% |
| 2007-12-31 | $139.29 Million | +39.64% |
| 2006-12-31 | $99.75 Million | -32.33% |
| 2005-12-31 | $147.40 Million | +187.55% |
| 2004-12-31 | $51.26 Million | +24.80% |
| 2003-12-31 | $41.07 Million | -0.69% |
| 2002-12-31 | $41.36 Million | -6.56% |
| 2001-12-31 | $44.27 Million | +1.78% |
| 2000-12-31 | $43.49 Million | -16.67% |
| 1999-12-31 | $52.19 Million | -6.82% |
| 1998-12-31 | $56.01 Million | +283.89% |
| 1997-12-31 | $14.59 Million | +18.08% |
| 1996-12-31 | $12.36 Million | +71.61% |
| 1995-12-31 | $7.20 Million | +75.61% |
| 1994-12-31 | $4.10 Million | +70.83% |
| 1993-12-31 | $2.40 Million | -- |
About Amedisys Inc
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services,… Read more